Real-life Pan-HER-blockade With Neratinib

Clinical trial NCT04388384 · COMPLETED

Trial details

NCT number: NCT04388384
Sponsor: Pierre Fabre Pharma GmbH
Status: COMPLETED
Study type: OBSERVATIONAL

Breast Neoplasm

Start date: 2020-07-02
Primary completion: 2024-09-05
Enrollment: 304

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.